Medical Evaluation Specialists is categorized under Doctors in Glen Ellyn, IL and active since 2008.
Medical Evaluation Specialists was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6219993 by the NAICS.
If you are seeking more information, feel free to contact Bill Eulger, Manager at the company’s branch by writing to 751 Roosevelt Road # 208, Glen Ellyn, Illinois IL 60137 or by phoning (630) 790-0732. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Evaluation Specialists |
| Contact Person: | Bill Eulger, Manager |
| Address: | 751 Roosevelt Road # 208, Glen Ellyn, Illinois 60137 |
| Phone Number: | (630) 790-0732 |
| Website Address: | mesgroup.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2008 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6219993 |
| Share This Business: |
Medical Evaluation Specialists was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bill Eulger, Manager for inquiries that concern Medical Evaluation Specialists by calling the company number (630) 790-0732, as your correspondence is most welcome. Additionally, the physical location of the branch of Medical Evaluation Specialists can be found at the coordinates 41.85935,-88.05499 as well as the street address 751 Roosevelt Road # 208 in Glen Ellyn, Illinois 60137.
For its online presence, you may visit Medical Evaluation Specialists’s website at mesgroup.com and engage with its social media outlets through on Twitter and on Facebook.